Hospital or health organisation · founded 1899
National Jewish Health
Denver, United States · nationaljewish.org
- Citations, last 5 years
- 32.7k
- Works, last 5 years
- 3 582
- h-index
- 613
- Scientists listed
- 215
- Grants since 2016
- 246
Grants received
2020–2024 · research · R01
Roles for interstitial and airspace macrophages in resolution of pulmonary inflammation
Peter M Henson · National Jewish Health · funded by National Institutes of Health
2020–2024 · research · R01
Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
Evans Fernandez · National Jewish Health · funded by National Institutes of Health
2020–2026 · research · R01
Role of immunoproteasome in airway viral infection
Hong W Chu · National Jewish Health · funded by National Institutes of Health
2020–2027 · cooperative agreement · U01
ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER
Elena Goleva · National Jewish Health · funded by National Institutes of Health
2019–2020 · career development · K23
Developing a Novel Decision Aid for Tracheostomy to Support Shared Decision-Making in the Intensive Care Unit
Anuj Mehta · National Jewish Health · funded by National Institutes of Health
2019–2024 · research · R01
Use of blinded tapering for hypnotic discontinuation
Jack D Edinger · National Jewish Health · funded by National Institutes of Health
2019–2024 · research · R01
Mechanisms of Right Ventricle Adaptation to Pulmonary Hypertension
Tim Lahm · National Jewish Health · funded by National Institutes of Health
2019–2022 · research · R01
Selenocyanate as a novel treatment of cystic fibrosis lung disease
Brian J Day · National Jewish Health · funded by National Institutes of Health
2019–2023 · research · R01
Temporal regulation of pulmonary inflammation by MyD88 alternative pre-mRNA splicing
Scott Alper · National Jewish Health · funded by National Institutes of Health
2019–2024 · research · R01
Reducing Fibroblast Persistence in Pulmonary Fibrosis as a Mechanism of Resolution
Elizabeth Frances Redente · National Jewish Health · funded by National Institutes of Health
2019–2021 · research · R21
Regulation of innate immunity by a novel protein interaction network
Scott Alper · National Jewish Health · funded by National Institutes of Health
2019–2023 · research · R01
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria
Jane Hill · National Jewish Health · funded by National Institutes of Health
2019–2023 · research · R01
Novel integrative approaches for disease phenotyping, utilizing radiomics in Sarcoidosis
Nichole Carlson · National Jewish Health · funded by National Institutes of Health
2019–2021 · research · R01
Role of Lung MSC in Emphysema
Susan M Majka · National Jewish Health · funded by National Institutes of Health
2019–2023 · research · R01
Novel integrative approaches for disease phenotyping, utilizing radiomics in Sarcoidosis
Nichole Carlson · National Jewish Health · funded by National Institutes of Health
2019–2024 · research · R01
Role of FABP5 in COPD Exacerbations
Fabienne Gally · National Jewish Health · funded by National Institutes of Health
2019–2024 · research · R01
Reducing Fibroblast Persistence in Pulmonary Fibrosis as a Mechanism of Resolution
Elizabeth Frances Redente · National Jewish Health · funded by National Institutes of Health
2019–2022 · research · R01
Selenocyanate as a novel treatment of cystic fibrosis lung disease
Brian J Day · National Jewish Health · funded by National Institutes of Health
2019–2022 · research · R01
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria
Jane Hill · National Jewish Health · funded by National Institutes of Health
2019–2020 · career development · K08
Mechanisms of AIRE SAND-Domain Variants in Autoimmunity
Jordan Abbott · National Jewish Health · funded by National Institutes of Health
2019–2024 · research · R01
Use of blinded tapering for hypnotic discontinuation
Jack D Edinger · National Jewish Health · funded by National Institutes of Health
2019–2020 · research · R13
2019 Aspen Lung Conference: Exploring new therapeutic pathways in pulmonary hypertension: metabolism, proliferation, and personalized medicine
Marjorie Patricia George · National Jewish Health · funded by National Institutes of Health
2019–2022 · research · R21
Regulation of innate immunity by a novel protein interaction network
Scott Alper · National Jewish Health · funded by National Institutes of Health
2019–2022 · research · R01
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria
Jane Hill · National Jewish Health · funded by National Institutes of Health
2019–2023 · research · R01
Temporal regulation of pulmonary inflammation by MyD88 alternative pre-mRNA splicing
Scott Alper · National Jewish Health · funded by National Institutes of Health
2019–2024 · research · R01
Use of blinded tapering for hypnotic discontinuation
Jack D Edinger · National Jewish Health · funded by National Institutes of Health
2019–2023 · research · R01
Role of FABP5 in COPD Exacerbations
Fabienne Gally · National Jewish Health · funded by National Institutes of Health
2019–2024 · research · R01
Reducing Fibroblast Persistence in Pulmonary Fibrosis as a Mechanism of Resolution
Elizabeth Frances Redente · National Jewish Health · funded by National Institutes of Health
2019–2028 · research · R01
Role of FABP5 in COPD Exacerbations
Fabienne Gally · National Jewish Health · funded by National Institutes of Health
2019–2028 · research · R01
Mechanisms of right ventricle adaptation to pulmonary hypertension
Tim Lahm · National Jewish Health · funded by National Institutes of Health
2018–2022 · cooperative agreement · UH3
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis
Gregory Paul Downey · National Jewish Health · funded by National Institutes of Health
2018–2021 · research · R21
Regulation of Humoral Immunity by SR Protein Kinase 3
James R. Hagman · National Jewish Health · funded by National Institutes of Health
2018–2023 · research · R01
Steroid resistance of airway ILC2s
Rafeul Alam · National Jewish Health · funded by National Institutes of Health
2018–2024 · cooperative agreement · U01
Optimization of AEOL10150 treatment of sulfur mustard-induced lung toxidrome in a pig model
Brian J Day · National Jewish Health · funded by National Institutes of Health
2018–2020 · career development · K99
Macrophage Metabolism After Target Cell Ingestion Regulates Anti-Inflammatory Reprogramming
Alexandra Leigh Mccubbrey · National Jewish Health · funded by National Institutes of Health
2018–2023 · research · R01
Steroid resistance of airway ILC2s
Rafeul Alam · National Jewish Health · funded by National Institutes of Health
2018–2025 · research · R35
Lung Macrophage Programming in Acute Lung Injury
William Janssen · National Jewish Health · funded by National Institutes of Health
2018 · prize · Medicine
Wolf Prize in Medicine 2018 — Philippa Marrack
Philippa Marrack · National Jewish Health · funded by Wolf Foundation
2018–2021 · research · R01
Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis
David W. Riches · National Jewish Health · funded by National Institutes of Health
2018–2024 · research · R01
Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD
Donna L Bratton · National Jewish Health · funded by National Institutes of Health
